Similar articles

• Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung.

  Saijo N, Shimizu E, Shibuya M, Irimajiri N, Takizawa T, Eguchi K, Shinkai T, Tominaga K, Shimabukuro Z, Taniguchi T, Hoshi A. Saijo N, et al. Br J Cancer. 1982 Aug;46(2):180-9. doi: 10.1038/bjc.1982.182. Br J Cancer. 1982. PMID: 6185128 Free PMC article.
• Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines.

  Kurai J, Chikumi H, Hashimoto K, Yamaguchi K, Yamasaki A, Sako T, Touge H, Makino H, Takata M, Miyata M, Nakamoto M, Burioka N, Shimizu E. Kurai J, et al. Clin Cancer Res. 2007 Mar 1;13(5):1552-61. doi: 10.1158/1078-0432.CCR-06-1726. Clin Cancer Res. 2007. PMID: 17332301
• An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells.

  Fantini M, David JM, Wong HC, Annunziata CM, Arlen PM, Tsang KY. Fantini M, et al. Cancer Biother Radiopharm. 2019 Apr;34(3):147-159. doi: 10.1089/cbr.2018.2628. Epub 2019 Jan 2. Cancer Biother Radiopharm. 2019. PMID: 30601063 Free PMC article.
• Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells In Vitro.

  Pham DH, Kim JS, Kim SK, Shin DJ, Uong NT, Hyun H, Yoon MS, Kang SJ, Ryu YJ, Cho JS, Yoon JH, Lee JS, Cho D, Lee SH, Park MH. Pham DH, et al. Anticancer Res. 2017 Oct;37(10):5507-5513. doi: 10.21873/anticanres.11981. Anticancer Res. 2017. PMID: 28982863
• Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition.

  Di Modica M, Sfondrini L, Regondi V, Varchetta S, Oliviero B, Mariani G, Bianchi GV, Generali D, Balsari A, Triulzi T, Tagliabue E. Di Modica M, et al. Oncotarget. 2016 Jan 5;7(1):255-65. doi: 10.18632/oncotarget.6353. Oncotarget. 2016. PMID: 26595802 Free PMC article.